CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Cash flows from operating activities:
Net loss	$ (169,590)	$ (148,315)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation	704	361
Amortization of intangibles	85,511	94,334
Amortization of deferred financing costs	2,440	2,730
Accretion of debt discount	3,590	2,286
Interest accretion of notes receivable	0	(127)
Deferred income tax expense (benefit)	(202)	6,746
Loss on disposal of fixed assets	35	19
Loss on extinguishment of debt	0	1,112
Stock compensation expense	2,718	5,944
Fair market value change in derivative liability	(8,935)	(19,315)
Fair market value change in contingent consideration	(11,652)	(138)
Issuance of stock for inducement	0	19,500
Loss on impairment	56,143	24,352
Decrease (increase) in operating assets (excluding effect of acquisitions):
Accounts receivable	11,009	(17,082)
Income taxes	5,321	(4,145)
Inventory	2,260	444
Prepaid expenses and other assets	(533)	2,471
Increase (decrease) in operating liabilities (excluding effect of acquisitions):
Accounts payable and accrued expenses	(7,958)	6,682
Accrued allowances	(1,717)	10,074
Arbitration award	17,522	0
Interest payable	(1,006)	2,291
Other liabilities	(2,161)	(4,973)
Net cash used in operating activities	(16,501)	(14,749)
Cash flows from investing activities:
Acquisitions	(583)	(87,986)
Payments received on notes receivable	0	4,850
Purchase of software and equipment	(984)	(1,212)
Net cash used in investing activities	(1,567)	(84,348)
Cash flows from financing activities:
Proceeds from issuance of Convertible Notes	0	130,000
Payments on Treximet Secured Notes	(20,406)	(10,013)
Net drawdowns (payments) on credit facilities	(1,000)	7,655
Payments for financing costs	0	(5,349)
Payment of consent fee	0	(2,150)
Payments on mortgages and capital leases	(77)	(44)
Proceeds from issuance of common stock, net of tax and costs	19,814	395
Shares withheld for the payment of taxes	(23)	(117)
Net cash (used in) provided by financing activities	(1,692)	120,377
Net (decrease) increase in cash and cash equivalents	(19,760)	21,280
Cash and cash equivalents, beginning of period	56,135	34,855
Cash and cash equivalents, end of period	$ 36,375	$ 56,135